Although AI holds great potential in optimizing and advancing clinical research, the risks and ethical concerns it presents must be considered when using it in clinical trials, the World Health Organization (WHO) cautions in a recent report.
Read More
Drug & Device Pipeline News - 6, 6 and 3 -
This week’s Pipeline features a phase 3 trial approval for retinitis pigmentosa, a phase 1 trial start for Parkinson’s disease with GBA1 mutations and an FDA drug expanded indication approval for HIV-1 infection.
Read More